Published date: 17 December 2025

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 20 February 2025, 5pm

Contract summary

Industry

  • Vaccines - 33651600

Location of contract

E14 4PU

Value of contract

£0

Procurement reference

CF-3307400D0O000000rwimUAA

Published date

17 December 2025

Closing date

20 February 2025

Closing time

5pm

Contract start date

19 September 2025

Contract end date

19 December 2026

Contract type

Supply contract

Procedure type

Call-off from a dynamic purchasing system

A mini-competition or direct purchase from a pre-established dynamic purchasing system.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Adults (2025/26).

The contract was awarded for Lot 2, Adult SARS-CoV-2 vaccines, via a further competition conducted under the SARS-CoV-2 vaccine DPS (FTS ref: 2024/S 000-026083).

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

More information

Attachments

Award information

Awarded date

19 September 2025

Contract start date

19 September 2025

Contract end date

19 December 2026

Total value of contract

£1

This contract was awarded to 1 supplier.

Aventis Pharma Limited T/a Sanofi

Address

410 Thames Valley Park Drive RG6 1PT

Reference

None

Supplier is SME?

No

About the buyer

Contact name

UK Health Security Agency

Address

10 South Colonnade
London
E14 4PU
GB

Email

vmc.vaccines@ukhsa.gov.uk